• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease.第九届高密度脂蛋白(HDL)研讨会会议记录:关注心血管疾病
Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):2457-2467. doi: 10.1161/ATVBAHA.119.313340. Epub 2019 Oct 10.
2
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.富含甘油三酯的脂蛋白和心血管疾病高危患者的高密度脂蛋白胆固醇:管理的证据和指导。
Eur Heart J. 2011 Jun;32(11):1345-61. doi: 10.1093/eurheartj/ehr112. Epub 2011 Apr 29.
3
Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.目前针对与心血管疾病相关的高密度脂蛋白的治疗方法。
Molecules. 2018 Oct 23;23(11):2730. doi: 10.3390/molecules23112730.
4
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.高密度脂蛋白胆固醇:心血管疾病管理中不断演变的治疗靶点。
Vasc Health Risk Manag. 2008;4(1):39-57. doi: 10.2147/vhrm.2008.04.01.39.
5
Role of non-high-density lipoprotein cholesterol in prevention of cardiovascular disease: updated evidence from clinical trials.非高密度脂蛋白胆固醇在预防心血管疾病中的作用:来自临床试验的最新证据。
Curr Opin Cardiol. 2003 Nov;18(6):503-9. doi: 10.1097/00001573-200311000-00012.
6
[Raising HDL cholesterol: which is the best strategy?].[提高高密度脂蛋白胆固醇:哪种策略最佳?]
Rev Assoc Med Bras (1992). 2008 Jul-Aug;54(4):369-76. doi: 10.1590/s0104-42302008000400025.
7
Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: recommendations of the HDL Forum.高密度脂蛋白胆固醇在心血管疾病风险预防中的意义:HDL论坛建议
Am J Cardiovasc Drugs. 2004;4(5):299-314. doi: 10.2165/00129784-200404050-00003.
8
HDL-Targeting Therapeutics: Past, Present and Future.靶向高密度脂蛋白的治疗方法:过去、现在与未来
Curr Pharm Des. 2017;23(8):1207-1215. doi: 10.2174/1381612822666161027153140.
9
Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?重新审视心血管疾病中的高密度脂蛋白胆固醇:好事过头就总是好事吗?
Prog Cardiovasc Dis. 2024 Nov-Dec;87:50-59. doi: 10.1016/j.pcad.2024.10.009. Epub 2024 Oct 21.
10
Targeting high density lipoproteins in the prevention of cardiovascular disease?靶向高密度脂蛋白在心血管疾病预防中的作用?
Curr Cardiol Rep. 2012 Dec;14(6):684-91. doi: 10.1007/s11886-012-0317-3.

引用本文的文献

1
HDL functionality is dependent on hepatocyte stress defense factors Nrf1 and Nrf2.高密度脂蛋白(HDL)的功能依赖于肝细胞应激防御因子Nrf1和Nrf2。
Front Physiol. 2023 Jul 12;14:1212785. doi: 10.3389/fphys.2023.1212785. eCollection 2023.
2
A Nutrigenetic Update on CETP Gene-Diet Interactions on Lipid-Related Outcomes.CETP 基因-饮食相互作用与血脂相关结局的营养遗传学更新。
Curr Atheroscler Rep. 2022 Feb;24(2):119-132. doi: 10.1007/s11883-022-00987-y. Epub 2022 Jan 31.
3
Familial Hypercholesterolemia: Do HDL Play a Role?家族性高胆固醇血症:高密度脂蛋白发挥作用吗?
Biomedicines. 2021 Jul 13;9(7):810. doi: 10.3390/biomedicines9070810.
4
Free fatty acid receptor 4 responds to endogenous fatty acids to protect the heart from pressure overload.游离脂肪酸受体 4 对内源性脂肪酸作出响应,从而保护心脏免受压力超负荷的影响。
Cardiovasc Res. 2022 Mar 16;118(4):1061-1073. doi: 10.1093/cvr/cvab111.
5
Coagulatory Defects in Type-1 and Type-2 Diabetes.1 型和 2 型糖尿病的凝血缺陷。
Int J Mol Sci. 2019 Dec 16;20(24):6345. doi: 10.3390/ijms20246345.

本文引用的文献

1
Whole egg consumption compared with yolk-free egg increases the cholesterol efflux capacity of high-density lipoproteins in overweight, postmenopausal women.相较于无蛋黄的鸡蛋,食用整个鸡蛋会增加超重、绝经后妇女的高密度脂蛋白胆固醇外排能力。
Am J Clin Nutr. 2019 Sep 1;110(3):617-627. doi: 10.1093/ajcn/nqz088.
2
SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis.SR-B1 通过 DOCK4 驱动内皮细胞 LDL 胞吞作用,从而促进动脉粥样硬化。
Nature. 2019 May;569(7757):565-569. doi: 10.1038/s41586-019-1140-4. Epub 2019 Apr 24.
3
Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.载脂蛋白A1治疗以I型清道夫受体B类依赖的方式保护小鼠免受阿霉素诱导的心脏毒性。
Am J Physiol Heart Circ Physiol. 2019 Jun 1;316(6):H1447-H1457. doi: 10.1152/ajpheart.00432.2018. Epub 2019 Apr 19.
4
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018 年美国心脏病学会/美国心脏协会/美国心血管血管造影和介入学会/美国预防、物理治疗和康复医师学会/美国糖尿病协会/美国老年学会/美国药学会/美国医师协会/美国生理学会/北美介入放射学会/美国国家脂质协会/美国临床内分泌医师协会胆固醇管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10.
5
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.依泽替米贝降低严重高甘油三酯血症患者心血管风险
N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.
6
A Targeted, Differential Top-Down Proteomic Methodology for Comparison of ApoA-I Proteoforms in Individuals with High and Low HDL Efflux Capacity.靶向、差异从上至下蛋白质组学方法比较高和低 HDL 外排能力个体的载脂蛋白 A-I 蛋白亚型。
J Proteome Res. 2018 Jun 1;17(6):2156-2164. doi: 10.1021/acs.jproteome.8b00100. Epub 2018 Apr 27.
7
High-density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation through SR-B1, PI3K, and AKT1 and 2.高密度脂蛋白通过 SR-B1、PI3K 和 AKT1 和 2 保护心肌细胞免受缺氧和葡萄糖剥夺引起的坏死。
Biochem J. 2018 Apr 5;475(7):1253-1265. doi: 10.1042/BCJ20170703.
8
Effects of Increasing Exercise Intensity and Dose on Multiple Measures of HDL (High-Density Lipoprotein) Function.增加运动强度和剂量对多种高密度脂蛋白(HDL)功能指标的影响。
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):943-952. doi: 10.1161/ATVBAHA.117.310307. Epub 2018 Feb 8.
9
Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids.代谢综合征中异常的脂蛋白氧化脂质和 ω-3 脂肪酸的部分纠正作用。
Prostaglandins Leukot Essent Fatty Acids. 2018 Jan;128:1-10. doi: 10.1016/j.plefa.2017.10.006. Epub 2017 Nov 11.
10
Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.非高密度脂蛋白胆固醇水平升高可导致 LGMD2B 小鼠模型的肌肉消耗和活动障碍。
J Lipid Res. 2018 Feb;59(2):261-272. doi: 10.1194/jlr.M079459. Epub 2017 Nov 25.

第九届高密度脂蛋白(HDL)研讨会会议记录:关注心血管疾病

Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease.

机构信息

From the Center for Vascular Biology, Department of Cell Biology, University of Connecticut Health, Farmington (A.R.).

Department of Biochemistry and Biomedical Sciences, McMaster University, and Thrombosis and Atherosclerosis Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada (B.L.T.).

出版信息

Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):2457-2467. doi: 10.1161/ATVBAHA.119.313340. Epub 2019 Oct 10.

DOI:10.1161/ATVBAHA.119.313340
PMID:31597448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6937204/
Abstract

The HDL (high-density lipoprotein) Workshop was established in 2009 as a forum for candid discussions among academic basic scientists, clinical investigators, and industry researchers about the role of HDL in cardiovascular disease. This ninth HDL Workshop was held on May 16 to 17, 2019 in Boston, MA, and included outstanding oral presentations from established and emerging investigators. The Workshop featured 5 sessions with topics that tackled the role of HDL in the vasculature, its structural complexity, its role in health and disease states, and its interaction with the intestinal microbiome. The highlight of the program was awarding the Jack Oram Award to the distinguished professor emeritus G.S. Getz from the University of Chicago. The tenth HDL Workshop will be held on May 2020 in Chicago and will continue the focus on intellectually stimulating presentations by established and emerging investigators on novel roles of HDL in cardiovascular and noncardiovascular health and disease states.

摘要

高密度脂蛋白(HDL)研讨会成立于 2009 年,是一个学术基础科学家、临床研究人员和行业研究人员之间就 HDL 在心血管疾病中的作用进行坦诚讨论的论坛。第九届 HDL 研讨会于 2019 年 5 月 16 日至 17 日在马萨诸塞州波士顿举行,会议包括知名和崭露头角的研究人员的精彩口头报告。研讨会设有 5 个专题讨论环节,涵盖了 HDL 在血管中的作用、其结构复杂性、在健康和疾病状态中的作用以及与肠道微生物组的相互作用。该计划的亮点是向芝加哥大学名誉教授 G.S.Getz 颁发杰出教授 Jack Oram 奖。第十届 HDL 研讨会将于 2020 年 5 月在芝加哥举行,将继续关注知名和崭露头角的研究人员就 HDL 在心血管和非心血管健康及疾病状态中的新作用进行富有启发性的报告。